PepRank

Lactotripeptides (VPP and IPP)

Also: valyl-prolyl-proline / isoleucyl-prolyl-proline · AmealPeptide (Calpis / Asahi) · VasoDrive-AP (pre-workout ingredient) · Evolus (Valio fermented milk)

SupplementOral

Fermented-milk ACE-inhibitor tripeptides; lower blood pressure by a few mmHg, best data in Japan.

Safety tier
Caution
strict bar
Positive
49%
of 4 reports
Per month
≈ €15–35
estimate
Rank
#9
of 23 supplements

At a glance

Access
Supplement
OralFelt in 4–8 weeks

Builds over days or weeks of regular use rather than with each dose.

Best effects
Modest blood-pressure reduction (2-6 mmHg systolic in trials) · vascular 'pump' in training (pre-workout users, stacked)
Downsides
Palpitations reported by one pre-workout user · light-headedness possible when stacked with nitrates or antihypertensives · effect too small to replace medication for real hypertension
Typical use
3-5 mg VPP+IPP per day (e.g. one Ameal tablet or ~500 mg AmealPeptide/VasoDrive-AP); trials ranged from 2.5 to 15 mg.
Stacked with
Stacked with
L-citrulline / nitrates: the pre-workout pump stack; additive vasodilation · lifestyle measures (salt, potassium, exercise): the realistic context for a 3-5 mmHg effect

Safety

Watch
Works as a mild ACE inhibitor: its effect adds to blood-pressure drugs and to nitrate/citrulline pump stacks, so people on antihypertensives should monitor for low blood pressure. The class effects of ACE-inhibitor drugs (cough, angioedema, high potassium) have not been reported at food doses.
Tier by safety barStrict CautionBalanced CleanEvidence only Clean
  • Seen harm0 of 3
  • Mechanism1 of 3
  • Data gap0 of 3
  • Silent harm1 of 3
  • Product0 of 3
Never if
Already on blood-pressure-lowering drugs, without monitoring · Cow's milk allergy
Why each score
Seen harm 0/3
Over 30 RCTs report no serious events, and five times the effective dose for four weeks caused no excessive blood-pressure drop; the one first-hand complaint is palpitations from a pre-workout product. Fekete et al. 2015: lactotripeptides and blood pressure, meta-analysis of 30 RCTs (PubMed 25608938) ↗Excess intake (5x) of VPP/IPP casein hydrolysate for 4 weeks, n=48: no excessive BP drop (PubMed 21389626) ↗r/Supplements: VasoDrive-AP heart palpitations ↗
Mechanism 1/3
Mild ACE inhibition that lowers systolic pressure by 3-6 mmHg in Japanese trials; additive hypotension with blood-pressure drugs is possible but weak at food doses. Fekete et al. 2015: lactotripeptides and blood pressure, meta-analysis of 30 RCTs (PubMed 25608938) ↗
Data gap 0/3
Japan's Food Safety Commission evaluated it for FOSHU status, a toxicology dossier exists, and over 30 RCTs cover more than a thousand people. Japan Food Safety Commission: FOSHU evaluation of lactotripeptide (VPP, IPP) products ↗Lactotripeptide toxicology dossier (Int J Toxicol 2005 supplement, PubMed 16419575) ↗Fekete et al. 2015: lactotripeptides and blood pressure, meta-analysis of 30 RCTs (PubMed 25608938) ↗
Silent harm 1/3
Low blood pressure would be felt as light-headedness, though a small fall is silent.
Product 0/3
OTC drinks, tablets and capsules (Japanese FOSHU products, AmealPeptide, VasoDrive-AP).

User reports

All 6 reports →
Users report
Almost nobody on Reddit takes these for blood pressure. The one clear blood-pressure report is a borderline-hypertensive user who found it lowered 'high normal' readings with fewer side effects than a prescription drug (under a doctor's eye). Most other reports come from the pre-workout crowd, where VasoDrive-AP at 250-1,000 mg is prized for vascular 'pumps', always stacked with citrulline, nitrates or glycerol. One user gets palpitations at 275 mg twice a week and cut back. Treat the user score as thin. Felt nothing: 1 of 6 reports; very few first-hand reports exist.
Positive 2Nothing 1Negative 1
  • r/NootropicsDepot· · 13 upvotesOriginal ↗

    This is an interesting ACE inhibitor derived from fermented milk that I've found to help with my "high normal" BP while having a pretty safe profile by all available research.

    PositiveOral · borderline high blood pressure

    AmealPeptide in place of a prescription antihypertensive, with physician aware; says it had fewer side effects than the drug

  • r/NootropicsDepot· · 3 upvotesOriginal ↗

    Gives a phenomenal pump as well.

    PositiveOral · pre-workout pump

    replying in the AmealPeptide thread

  • r/Preworkoutsupplements· · 2 upvotesOriginal ↗

    I’m not a very high responder and only get a good pump every once in awhile even with proper carb loading, diet, water, cycling pres, little to no caffeine, etc.

    NothingOral · pre-workout pump

    self-described low responder listing VasoDrive-AP among pump ingredients tried in pre-workouts without a reliable pump

Studies

Evidence
Human RCTs — 30+ RCTs and several meta-analyses; consistent 3-6 mmHg systolic drops in Japanese trials but small or null effects in European ones, with publication bias. EFSA rejected the blood-pressure claim three times (2009, 2011, 2012). In Japan it is an approved FOSHU 'for those with high-normal blood pressure'.
Caveat
Results depend heavily on population: clear in Japanese trials, weak or null in European ones, and EFSA has not accepted the claim. The other food peptides sold for blood pressure work the same way (ACE inhibition): the bonito-flake peptide LKPNM (PeptACE/Vasotensin) and the sardine peptide valyl-tyrosine, both also FOSHU-listed in Japan, with even less Western data. Only about six first-hand Reddit reports exist, mostly from pre-workout users.
1 more study and 3 sources

Sources

Molecule

Sequence
VPP
Length
3 amino acids
Modifications
mixture of VPP + IPP (milk casein tripeptides)

Sequence

The peptide's chain of amino acids from its start (the N-terminus) to its end, one bead and one letter for each: A alanine, C cysteine, D aspartic acid, E glutamic acid, F phenylalanine, G glycine, H histidine, I isoleucine, K lysine, L leucine, M methionine, N asparagine, P proline, Q glutamine, R arginine, S serine, T threonine, V valine, W tryptophan, Y tyrosine. A modification such as an N-acetyl cap or a C-terminal amide changes how long it lasts in the body. Length tells related peptides apart, from a two-residue dipeptide like carnosine to a 43-residue protein like thymosin beta-4, and predicts neither effect nor safety.

Report grades

Every first-hand Reddit or X report is graded on its own, from glowing through positive, mixed, nothing and negative to bad reaction, and the bar shows how those grades split. Posts that look vendor-adjacent stay on the peptide's page but are left out of the counts.

GlowingPositiveMixedNothingNegativeBad reaction

% positive

The share of a peptide's graded Reddit and X reports that are glowing or positive, vendor-adjacent posts left out. A peptide with few reports is pulled toward the average of all reports, as if it had eight average ones besides its own, so two glowing posts cannot top the list. Peptides rank by this figure, those with no graded report yet after those with one, and Avoid ones after every other entry.

Researcher estimate

No first-hand report of this peptide has been graded yet, so the figure is the researchers' own rating out of 10 from what they read about it. It ranks after every peptide with graded reports until its own arrive.

Safety tier

Each peptide is tiered Clean, Caution or Avoid from its five risk axes under the chosen safety bar. An Avoid peptide carries a real risk of harm, a plausible route to serious harm rather than mere unpleasantness, so it stays listed with the reason but ranks behind every other entry, however good its reviews.

Safety bar

The safety bar sets how much risk it takes to rate a peptide Avoid. Strict: out on any serious mechanism with little human data, or any documented serious harm. Balanced: out on documented serious harm (unless it is obvious, reversible and from a regulated product), or a serious mechanism whose harm would be silent with no human data at all. Evidence only: out only on documented serious harm in humans that is lasting, delayed or from grey-market product.

Seen harm

Documented serious adverse events in humans, from 0 for none despite real exposure to 3 for deaths or several well-documented serious harms. Serious means a hospital or emergency visit or harm lasting weeks, so a headache or a bad night does not count.

Mechanism

A plausible biological route to serious harm at the doses people use, such as growth-factor signalling, hormone-axis suppression, heart or blood-pressure effects or immune activation. It runs from 0 when none is known to 3 when a dangerous pathway has been shown in living animals.

Data gap

How little human safety data exists for the molecule actually sold, from 0 for an approved drug with large trials and years of use to 3 for no human safety data at all. A modified analogue does not inherit its parent's trials.

Silent harm

Whether the feared harm would show quickly or stay hidden, from 0 when it is obvious and goes on stopping to 3 when it is silent and delayed, like tumour promotion or slow organ damage. User reports cannot reveal a harm that takes years to appear, so a high score here limits what good reviews can tell you.

Product

The risk of what people actually buy, from 0 for a regulated pharmacy or supplement product taken by mouth or on the skin to 3 for a grey-market injectable. In one dataset of 6,441 grey-market samples, 42–71% failed basic quality criteria and 15% carried endotoxin; taken by mouth or in the nose, a pack avoids the injection risks.

Evidence

The strongest kind of study behind the peptide's effects, from an approved drug through human controlled trials and small human studies to animal work or nothing of its own. Animal results often fail to carry over to people.

Access

How people get it: as an approved drug, a compounded prescription, an over-the-counter supplement or from the grey market, where nobody checks the vial. The channel decides both the legal position and the risk of a bad batch.

Price per month

Thirty days of the typical dose, from its low end to its high end, priced at the listing a careful buyer would choose: in stock, from a shop scoring 4 of 5 on trust (third-party tested where no score is set), failing that 3, a pure pack before a blend, a European shop first, then the cheapest per mg. The range is the dose's, not the shops'. A per-dose amount counts once a day unless the dose says otherwise. Prices are in euros at ECB rates of 2026-10-29, before shipping; the shop table keeps each listing's price per mg, per gram for bulk supplements. Where no listing can be priced the researchers' own estimate stands in, and says so.

Dose users report

The middle half of the daily doses stated in at least five first-hand reports, vendor posts left out. Where its middle sits more than twice above or below the declared dose, the month is priced at it as well, since what people take is what they pay for.

Shop trust

Each shop's trust on a 1–5 scale, read from its testing and its reputation: 1 for serious red flags (fabricated COAs, scam reports, impersonation, a closed shop), 2 for no public testing, a new shop or active complaints such as seized parcels, 3 for its own COAs or a short track record, 4 for verified third-party testing or a strong reputation, and 5 for third-party batch reports that name the shop, with years of good independent reputation. A shop without a score counts third-party batch testing as 4, its own COAs as 3 and no public tests as 2.

Best value

Within a category or a goal, a peptide that no other beats on both counts: none is rated more positively for the same or a lower monthly price, and none costs less for the same or a higher rating. The chart joins these into the best-value line; the cheapest of them and the best-rated of them both make it, so the line spans the trade-off from cheap to best. Avoid entries never count, and a peptide needs both a % positive and a price to be compared.

Testing

Whether the shop publishes lab results: third-party tested means an independent lab checks each batch, own COA means the shop's own certificate of analysis, and no public tests means neither. A certificate shows purity, not safety.

Added peptide

Some packs sold under one peptide's name hold a second one, such as 5 mg GHK-Cu in a nasal kit, stated only in the description. Sprayed in the nose or injected it reaches the blood like an injection, so it carries the risk of that route and is tiered as the injectable form, whatever its tier on the skin. A pack whose page gives no contents list may hold more than its name.